This chapter reviews the expression and role of Ets-genes during embryogenesis of amphibians and birds. In addition to overlapping expression domains, some of them exhibit cell type-speci®c expression. Many of them are expressed in migratory cells: neural crest, endothelial, and pronephric duct cells for instance. They are also transcribed in embryonic areas aected by epitheliomesenchymal transitions. Both processes involve modi®cations of cellular adhesion. Ets-family genes appear to coordinate changes in the expression of adhesion molecules and degradation of the extracellular matrix upon regulation of matrix metalloproteinases and their speci®c inhibitors. These functions are essential for physiological processes like tissue remodelling during embryogenesis or wound healing. Unfortunately they also play a harmful role in metastasis. Recent studies in the nervous system showed that Ets-genes contribute to the establishment of a cellular identity. This identity could rely on de®nite cell-surface determinants, among which cadherins could play an important role. In addition to cell-type speci®c expression, other factors contribute to the speci®city of function of Ets-genes. These genes have a broad speci®city of recognition of target sequences in gene promoters, insucient for accurate control of gene expression. A ®ne tuning could arise from combinatorial interactions with other Ets-or accessory proteins.
Introduction
The Ets-family of transcription factors, comprising more than 30 dierent members, is characterized by the presence of a DNA-binding domain of roughly 85 amino-acids. It is highly conserved from lower metazoans to humans (for review, see Graves and Petersen, 1998; Ghysdael and Boureux, 1997; Laudet et al., 1999; Papas et al., 1997) . Ets-proteins can be classi®ed into subclasses (Ghysdael and Boureux, 1997) , according to position and similarities in their Ets-domain and the presence of additional conserved sequences, essential for their function. Numerous results have accumulated, demonstrating their importance in ontogenic processes, as intermediates in integrating, at the nuclear level, dierent signalling pathways. They constitute a complex network of regulatory molecules. They have been ascribed a harmful role in development and progression of tumours (Dittmer and Nordheim, 1998; Hromas and Klemsz, 1994) . However, the interplay between dierent members and/or isoforms of a given protein has not yet been elucidated. Recent results concerning the expression of several members of the family in the nervous system have raised new interest for this family of genes and their contribution to de®ning cellular identity.
This chapter will focus on the expression patterns of genes belonging to the Ets-family, in the embryonic development of Xenopus and chicken. Their roles in controlling the balance between dierentiation and proliferation in the course of developmental processes will then be examined, with a special emphasis on transitions between epithelium and mesenchyme and on cellular migration. Finally, the basis for their functional speci®city will be discussed, in terms of unique cell type expression and combinatorial regulation.
A complementary review on Ets-genes expression during embryogenesis of mammals is developed in this volume by I Maroulakou and D Bowe.
Expression patterns

Xenopus
Xl-Ets-1: (EMBL accession numbers: X52691, X52692); two dierent cDNAs of the Ets-1 gene have been characterized . The longest encodes a putative polypeptide corresponding to the chicken p54 c-ets-1 protein. Two major transcripts of 4.4 and 7.5 kb have been detected by Northern blotting from early oogenesis to late embryogenesis (stage 40; Stiegler et al., 1993) . Whole-mount hybridization revealed that maternal Xl-Ets-1 transcripts are present from stage II of oogenesis and are localized to the animal pole of the oocytes from stage IV onwards . The expression pattern is further restricted to the animal subcortical region in the cleavage stage embryos. Small amounts of transcripts are found at the germinal plasm, suggesting a role in germinal lineage dierentiation. The zygotic transcription starts ubiquitously at the mid-blastula transition (stage 7 territory. A second domain of expression consists of the premigratory and migrating neural crest cells (cranial, vagal and truncal) . Simultaneously, expression is observed in a crescent-shaped zone just in front of the anterior-most part of the neural plate, the prospective territory for lens (Henry and Grainger, 1990) . Xl-Ets-1 transcripts are also found in dierent derivatives of neural crest cells: mesenchymal cells of the head and branchial arches, cranial-and dorsal roots ganglia. A mesenchymal expression of Xl-Ets-1 is also observed in the dorsal ®n and tail-bud tip, in agreement with the expression in migrating neural crest cells and their derivatives (Collazo et al., 1993; Sadaghiani and Thiebaud, 1987) . Finally, Xl-Ets-1 transcripts are found in the endothelial cells (ECs) of the forming heart and blood vessels.
In the adult, expression of Xl-Ets-1 appears to be restricted to the ovary and spleen .
Xl-Ets-2: (EMBL accession numbers: X51826, X52635 and M81683); for Xl-Ets-2, two dierent cDNAs were characterized (Burdett et al., 1992; Wol et al., 1991 Wol et al., , 1990 . A major (3.2 kb) and a minor (1.7 kb) transcripts were detected by Northern blotting from the very beginning of oogenesis to late embryogenesis (stage 40 at least; Wol et al., 1991) . Xl-Ets-2 was shown to be indispensable for meiotic maturation (Chen et al., 1990) . Whole-mount hybridization showed that the expression pattern of XlEts-2 during embryogenesis is remarkably similar to that of Xl-Ets-1. A few exceptions were observed: (i) whereas Xl-Ets-1 is strongly expressed in the presumptive territory for heart and blood islands, Xl-Ets-2 only gives a very faint signal. Conversely, whereas Xl-Ets-1 does not give a convincing signal at the level of forming pronephros and pronephric duct, Xl-Ets-2 is strongly and speci®cally expressed in those epithelial structures, in agreement with the results described in the mouse by Maroulakou et al. (1994) . During metamorphosis, Xl-Ets-2 was found expressed in several areas of the digestive track, essentially at the level of rapidly growing muscular cells .
In the adult, Xl-Ets-2 transcripts were detected by Northern blotting in a large variety of tissues (ovary, spleen, kidney, eye, muscle, stomach, liver, brain and, at the limit of detection, in heart and testes) (Wol et al., 1991) . This contrasts with the highly restricted expression depicted earlier by Chen et al. (1990) in the ovary.
XrpFI: (EMBL accession numbers: X91241, X91242, X91243); this is the amphibian homologue of the GABP gene (LaMarco et al., 1991; Thompson et al., 1991) . One incomplete cDNA encoding the a subunit was isolated; two other cDNAs code for the entire b subunit. They were isolated from Xenopus oocyte and embryo libraries (Gorgoni et al., 1995) . a-related transcripts (4.1 and 3.2 kb) and b-ones (2.4 and 3.6 kb) are present throughout oogenesis and embryogenesis, as shown by Northern blotting and in situ hybridization, using digoxigenin-labelled probe. Although the transcripts coding for the a and b subunits are constantly present, the b-polypeptide is not found in the cleavage stage embryo (Marchioni et al., 1993) , demonstrating the existence of a posttranscriptional control. No data were published on the expression in the adult.
XER81: (EMBL accession numbers: AF107662 and AF057565): the Xenopus homologue of mouse and human ER81 belongs to the PEA3 subfamily of Etstranscription factors. cDNAs corresponding to the XER81 gene were isolated from restricted Xenopus libraries: ventral halves of gastrula embryos, (MuÈ nchberg and Steinbeisser, 1999) or activin-induced animal caps (Chen et al., 1999) . Northern blot analysis revealed the existence of three transcripts (of 3, 4 and 6 kb), expressed maternally and zygotically. The 3 kb mRNA appears to be the most abundant maternal transcript. Its level decreases during gastrulation, neurulation and tailbud stages. The 4 and 6 kb transcripts showed a similar time-course of expression, with the dierence that a signi®cant increase in expression was detected between gastrula and neurula (Chen et al., 1999; MuÈ nchberg and Steinbeisser, 1999) . A study of the expression of the transcripts in the dierent germ layers did not give any clue for a speci®c expression in ectoderm or mesoderm with respect to the whole embryo. Accordingly, activin-induced animal caps exhibit high levels of all three transcripts. Wholemount and in situ hybridization on sections were carried out using digoxigenin-labelled probes, throughout embryogenesis (Chen et al., 1999; MuÈ nchberg and Steinbeisser, 1999) . Both groups reported a localization of maternal transcripts to the animal pole of the blastula embryo, similarly to the observations reported for Xl-Ets-1 and Xl-Ets-2 . The similarity is maintained further, as XER81 is expressed at high levels in the marginal zone during gastrulation. In neurula stages, XER81 is ®rst expressed rather homogeneously in the neural plate, the expression domain being later re®ned to discrete subdomains of fore-, mid-and hindbrain, prospective lens area, anterior half of the otic vesicle, anterior and posterior mesoderm, branchial arches, heart anlage, tail tip and pronephros. XER81 was shown to be a target of the FGF signalling pathway (MuÈ nchberg and Steinbeisser, 1999) and to interfere with activin signalling, when ectopically expressed in animal caps (see below).
In the adult, an RT/PCR survey (Chen et al., 1999 ) revealed a broad expression of XER81. The highest levels of transcripts were found in ovary and kidney; strong signals were also observed in neural derivatives such as eye and brain, as well as in stomach. Other tissues (bladder, fat body, gut, heart, intestine, liver, lung, muscle, spinal cord, skin, spleen, testis) revealed only very low levels of transcripts, in many instances hardly above background.
Xl-Fli-1: (EMBL accession number: X66979): screening of a Xenopus lgt10 library yielded a single 4.4 kb cDNA, containing the entire open reading frame of XlFli-1 . A partial reconstitution of the exon ± intron structure showed that the gene is heavily split, as already observed for chicken Ets-1 and human Ets-2 genes (Watson et al., 1990) . The basis therefore exists for dierential splicing, as previously reported for other members of the Ets-family. Northern blotting studies revealed that the Xl-Fli-1 gene is expressed from early neurula (stage 13/14) onwards. A major transcript (& 4.5 kb) accumulates from stage 13/14 to stage 40 at least. A second hybridizing species (& 7 kb) appears somewhat later (stage 23) and accumulates as the 4.5 kb transcript does. More recent experiments suggest that this second hybridizing species is actually a transcript of the Xl-Erg gene (Baltzinger et al., 1999; see below) . In situ hybridization on embryo sections using a radioactive probe provided evidence for a speci®c expression of Xl-Fli-1 along the neural crest cell migration pathway. Whole-mount hybridization using digoxigenin-labelled probes, later allowed a more complete description of Xl-Fli-1 cellular speci®city (Meyer et al., 1995) . The earlier transcript was observed in the ventral anterior region, prospective anlage for heart and blood islands, probably at the level of primitive angioblasts. Expression in primitive hemangioblasts is supported by the observation of cells sticking to the outer surface of the neural tube and strongly positive for Xl-Fli-1. Indeed, angioblasts were shown to dierentiate in the vicinity of the neural tube, in a ventro-dorsal and rostro-caudal pathway, to ensure the vascularization of the neural tube through angiogenesis (Bischo, 1995; Feeney and Watterson, 1946) . Accordingly, a strong expression is later observed in ECs of the forming endocardium and blood vessels, as earlier described for Ets-1 in chicken (Vandenbunder, 1989; see farther) . Expression in the cranial neural crest cells was detected at premigratory and migrating stages, as well as in their derivatives. A diuse expression was also observed along the pronephric duct migration pathway, at a stage where the epithelial structure of the latter is not yet established.
In the adult, Xl-Fli-1 transcripts were observed in a restricted number of tissues (spleen, lungs, kidneys, brain, heart and at the limit of detection in muscles). A very short (&0.9 kb) transcript is consistently observed in testis. Its homogeneous size would argue against a degradation product. A similar result was reported by Prasad et al. (1992) .
Xl-Erg: (EMBL accession numbers: AJ224125; AJ224126); two dierent cDNA clones of the Xl-Erg gene (Xl-ErgA and Xl-ErgE) were isolated, diering in their 5'-region and by the presence (Xl-ErgA) or absence (Xl-ErgE) of a short internal exon (Baltzinger et al., 1999) . Northern blotting revealed the existence of a 6 kb transcript from stage 23 to stage 45 at least. However, RT/PCR experiments revealed a complex population of mRNAs (not resolved in the Northern blot experiment) and resulting from alternative splicing. Whole-mount hybridization using digoxigeninlabelled probes revealed an early expression in the ventral region, where vitelline veins will form. From stage 27, transcripts are detected in the vitelline veins, posterior cardinal veins and blood vessels of the head. At stage 32, intersomitic blood vessels become strongly positive for the expression of Xl-Erg. Parallel expression is observed in the ECs of the forming heart. In agreement with the rather general expression of Etsfamily genes in neural crest cells, Xl-Erg transcripts are present in the neuroectodermal compartment of the branchial arches. Although this expression pattern is remarkably similar to the one of Xl-Fli-1, minor qualitative dierences can be observed. For instance, the expression level of Xl-Erg is much lower than that of Xl-Fli-1 in the neuroectodermal compartment of the hyoid arch. Furthermore, a sub-population of cells of neuroectodermal origin, in the ®rst branchial arch is strongly labelled by a Xl-Fli-1 probe, but express XlErg hardly above background. These observations would plead for a complementarity of function of both genes rather than for a total redundancy.
In the adult, Xl-Erg expression was observed in the spleen, skin, kidneys and liver (Baltzinger, M, unpublished results) .
Chicken
Ck-Ets-1: (EMBL accession numbers: M21823; M22462; X13026; X13027); the transforming component of the E26 retrovirus was shown to have a cellular progenitor called c-Ets (Leprince et al., 1983) , transcribed as a major 7.5 kb mRNA in several chicken cell lines. Minor transcripts of 2 and 2.2 kb were also characterized. They were shown to be preferentially expressed in lymphoid cells (Chen, 1985) . A second locus homologous to the v-ets oncogene was characterized in the human genome, corresponding to the Ets-2 gene (Watson et al., 1985) . Antibodies raised against the trimeric fusion protein encoded by E26 allowed the characterization of a 54 kD protein, p54 c-ets-1 , essentially present in the cytoplasm of most cell lines and tissues tested, including bone marrow cells and circulating lymphocytes (Ghysdael et al., 1986b) . p54 c-ets-1 , together with a minor but closely related 56 kD protein was found at high levels in chicken thymocytes and bursal lymphocytes. At the same time, another set of proteins with molecular masses from 60 ± 64 kd and immunologically related to p54 c-ets-1 were characterized (Ghysdael et al., 1986a) and later attributed to the Ets-2 locus (Boulukos et al., 1990) . They were found at high levels in normal and transformed chicken macrophages, but not in avian cells corresponding to immature stages of the myeloid dierentiation pathway. Several cDNAs from the Ets-1 locus were cloned and sequenced (Chen, 1988; Duterque-Coquillaud et al., 1988; Leprince et al., 1988; Watson et al., 1988) . Evidence for alternative splicing of Ets-1 transcripts was brought by , allowing the synthesis of a second protein called p68 c-ets-1 , diverging from p54 c-ets-1 in its aminoterminal region. The corresponding mRNA was found expressed in normal chicken spleen, but not in thymus, nor in various T-lymphoid cell lines. Transcription of the mRNA encoding p68 c-ets-1 was later shown to be due to alternative promoter usage (Crepieux et al., 1993) . Other isoforms of human p54 c-ets-1 were also described, lacking either exon VII or IV or both (Jorcyk et al., 1991) .
Early in situ hybridization experiments revealed that Ck-Ets-1 was expressed in a much wider pattern than initially realized (Vandenbunder et al., 1989) . In the 7-somite embryo, Ck-Ets-1 was found strongly expressed in the ECs of extra-embryonic blood islands, in the forming embryonic blood vessels, in the forming heart endothelium, during angiogenesis in the nephric blastema and later in the ECs of the sinusoids between the tubules of the mesonephros and in the glomeruli. Ck-Ets-1 expression in ECs was found to be transitory, suggesting that it becomes extinct in the quiescent state that is characteristic for most mature ECs. In addition to ECs and precursors, mesencephalic and truncal neural crest cells also strongly expressed Ck-Ets-1. All these results raised the possibility that Ck-Ets-1 is expressed in proliferating cells. A con®rmation was searched by the association of bromodeoxyuridine incorporation and in situ hybridization, during feather morphogenesis in the chick embryo (Desbiens et al., 1991) . This study con®rmed the strong expression of Ck-Ets-1 in ECs, from the earliest blood-vessel-forming cell clusters to the new capillaries in the pulp of the feather ®laments. However, no BrdU incorporation could be detected in these ECs, suggesting that Ck-Ets-1 expression is associated with the dierentiation or migration of the ECs, parallel to the expression already described in migrating neural crest cells (Vandenbunder et al., 1989) . However, these early experiments did not allow distinguishing speci®c sites of expression for p54 c-ets-1 and p68 c-ets-1 . A ®rst immunoprecipitation approach revealed that p68 c-ets-1 is expressed in a fraction of the spleen which is composed of blood vessels, stroma of the spleen and probably tightly associated hematopoietic cells, but not in the lymphoid cells of this organ (Leprince et al., 1990) . A more detailed comparison of p54 c-ets-1 and p68 c-ets-1 expressions in the chick embryo was carried out by Queva et al. (1993) . p54 c-ets-1 is expressed homogeneously in mesodermal cells undergoing extensive reorganization and in ECs during angiogenesis, whereas p68
c-ets-1 is only expressed in a subset of these cells, randomly distributed in the population. Further dierences between the expression patterns of the two transcripts were observed. Whereas p54 c-ets-1 and p68
c-ets-1
were found expressed in immature erythroid cells, in accordance with the transforming properties of the E26 retrovirus, p68 c-ets-1 was never detected in lymphoid cells. More recently, Turque et al. (1997) Ck-Ets-2: (EMBL accession number: X07202); initial studies by Watson et al. (1985) have shown the existence of two loci Ets-1 and Ets-2 on dierent chromosomes in humans. In chicken, Western blotting revealed the existence, beside p54 c-ets-1 , of immunologically related proteins (Ghysdael et al., 1986a,b) , which were later recognized as the products of the Ck-Ets-2 locus (Boulukos et al., 1988) . These last authors reported the isolation of a new cDNA of the Etsfamily, encoding proteins of 58, 60, 62 and 64 kd, corresponding to the Ck-Ets-2 gene products. Sequence comparison to human Ets-2 gene con®rmed that this cDNA was transcribed from the chicken Ets-2 locus, giving rise to a major 4.0 kb RNA in many dierent cell types. The level of transcription of Ck-Ets-2 was increased in AMV-transformed myeloblasts induced to dierentiate in macrophages upon treatment with TPA (Ghysdael et al., 1986a) or other PKC activators (Boulukos et al., 1990) . Outside studies carried out on various normal or transformed chicken cell lines, no data concerning Ck-Ets-2 expression in embryos or adults were reported.
Cc-Fli-1: (EMBL accession numbers: Y14773; Y14774); two dierent cDNAs of the Fli-1 gene have been described in the quail (Coturnix coturnix; Mager et al., 1998) . They dier in their 5'-UTR and beginning of the coding sequence. They could arise from alternative splicing. However, several arguments support the existence of a second promoter, 1 kb upstream of the promoter already described in human and mouse (Barbeau et al., 1996) . Transcription under the control of this second promoter yields a cDNA encoding a shorter polypeptide, lacking the ®rst 33 amino-acids with respect to the protein synthesized from the proximal promoter, as similarly found for the human Erg gene (Duterque-Coquillaud et al., 1993) . In situ and whole-mount hybridization revealed the expression of Cc-Fli-1 gene in embryonic tissues very similar to those observed in Xenopus. Studies in quail-chick chimeras showed a marked expression in migrating neural crest cells. Whereas in Xenopus the Xl-Fli-1 gene was found expressed in cranial neural crest cells at premigratory stages, Cc-Fli-1 only appears expressed in the quail neural crest cells when they start to settle in the branchial arches. Double-labelling of the migrating neural crest cells with HNK-1 antibody and Fli-1 probe demonstrated that only the cranial neural crest cells with a mesectodermal destiny express Fli-1, at the exclusion of neural crest cells giving rise to a neural progeny. This lineage restriction was not observed at early stages for Ets-1, since this gene is expressed in migrating neural crest cells in the trunk of the avian (Vandenbunder et al., 1989) , murine (Maroulakou et al., 1994) and Xenopus embryos . In addition to neural crest cells and their derivatives, CcFli-1 is also expressed in the somatopleura, when it is colonized by extrinsic progenitors for ECs and in the splanchnopleura where endogenous angioblasts are generated (Pardanaud et al., 1996) . This correlation is strengthened by a later expression in the ECs of forming blood vessels. In the heart endothelium, a strong expression of Cc-Fli-1 is detected at the time they start their transition to mesenchyme and their migration through the cardiac jelly to build up septa and valves (Mager et al., 1998) . The expression in ECs is restricted to early development and is not linked to the maintenance of the endothelial function. Cc-Fli-1 expression could also be linked to commitment of the primitive hemangioblasts to the erythroid lineage, as attested by its expression in splanchnopleura and aortic clusters at E3. Gain of function experiments in Xenopus support this hypothesis (Remy et al., 1996) , as heterotopic expression of Xl-Fli-1 in embryos leads to the formation of ectopic`pockets' of mature erythrocytes. Parallel to Ets-2 and Erg (Dhordain et al., 1995; Maroulakou et al., 1994; Sumarsono et al., 1996; Vlaeminck-Guillem et al., 2000) , Cc-Fli-1 transcripts are detected in all precartilaginous and cartilaginous condensations (Mager et al., 1998) , arising either from the neuroectoderm (cartilages of the head and neck), or from the mesoderm (vertebra and limbs).
Ck-Erg: (EMBL accession number: X77159); a parallel study with Ck-Ets-1 was reported by Dhordain et al. (1995) . Northern blotting showed an expression domain much wider than the one initially reported in humans (Watson et al., 1992) , where transcripts were only detected in the thymus. In addition, Erg transcripts were detected in several transformed cell lines and in pre-B and B-cell lines (Prasad et al., 1994; Rivera et al., 1993; Rao et al., 1987; Reddy et al., 1987) . A single cDNA was isolated from a chicken spleen cDNA library. It encodes a putative polypeptide corresponding to the human p55 erg . Two transcripts (3.2 and 3.6 kb) were characterized by Northern blotting. They were present at high level in chicken embryo ®broblasts, as well as in muscle, brain, heart, lung and bursus of Fabricius of newborn chicken. Surprisingly, only low levels of transcription were observed in the thymus and total embryos at E2/E3. In situ hybridization revealed a striking homology with Ets-1 expression. At E1, both genes are expressed in the extraembryonic blood islands. At E2, transcripts appear in the walls of small blood capillaries, in the endothelium of the aorta and in the forming endocardium. Ck-Ets-1 and Ck-Erg are highly expressed in mesenchymal cells. Only a minor dierence is reported: Ck-Erg is expressed in a subset of the cells expressing Ck-Ets-1. At E3, Ck-Erg and Ck-Ets-1 are still expressed in ECs of blood vessels, as well as in other tissues of mesodermal origin. Dierences start to emerge: (i) in the mesenchyme surrounding the dorsal root ganglia, the expression of Ck-Erg is much lower than that of Ck-Ets-1; (ii) Ck-Erg is not expressed in the mesonephritic blastema, contrary to Ck-Ets-1; (iii) Ck-Erg is expressed in the dermatome and sclerotome. At E6, Ck-Erg starts to be expressed in the precartilaginous condensations. Very recent results (Iwamoto et al., 2000) show that Ck-Erg is transcribed as two dierent mRNAs, diering by the presence or absence of a short internal region, as already described for the Xenopus Xl-Erg gene (Baltzinger et al., 1999) and for humans (Prasad et al., 1994; DuterqueCoquillaud et al., 1993) . These transcripts are expressed dierentially in chondrocytes and have dierent functions. The shorter isoform of the Erg protein maintains chondrocytes in an immature state, whereas the longer isoform favours maturation of chondrocytes, accompanied by mineralization (Iwamoto et al., 2000) . Erg transcripts were also present in neural crest cells and their derivatives, in agreement with observations in Xenopus (Baltzinger et al., 1999) and mouse (Vlaeminck-Guillem, et al., 2000) .
Ck-Spi-1/PU.1: (EMBL accession number: Y12225); a single cDNA was cloned by Kherrouche et al. (1998) , exhibiting a high homology with the human and mouse homologues. Northern blotting showed the existence of two transcripts (2.1 and 2.9 kb), essentially present in the spleen and bursus of Fabricius in the 19-day embryo. Overexposure of the Northern blots also revealed an expression at very low levels in the thymus and bone marrow. No PU.1 transcript could be detected in younger embryos (at 3 and 9 days). A very strong expression was reported in a macrophage cell line. Transcripts were also found in a myeloblastic cell line, in B-lymphoma cells, in a myeloid as well as in an erythroid cell lines. In situ hybridization, carried out on dierent organs of the 19-day embryo, showed a high-level transcription in B-cell follicles of the bursus of Fabricius. In the spleen, an intense expression is observed in the nodal white pulp, at the exclusion of the red pulp (erythroid area). In the white pulp, expression was associated to B-and macrophages cell types. Contrary to Northern blotting, in situ hybridization revealed high levels of transcripts in the thymus, at the level of macrophage-like cells, in the medulla and trabecula. These results are in complete agreement with the cell types expressing Spi-1/PU.1 in mammals (Klemsz et al., 1990; Ray et al., 1992) and with its function in hematopoiesis (Barnache et al., 1998 , Moreau-Gachelin et al., 1996 .
Ck-PEA3 subgroup: cDNAs for ERM (EMBL accession number: AF075706), ER81 (AF075708), PEA3 (AF075707) were characterized (Lin et al., 1998) . The preceding authors reported a remarkable study of the coordinated expression of a homeobox gene (LIM-family) and PEA3 Ets-family members in pools of spinal motor and sensory neurons. Using¯uorescence immunocytolocalization and confocal imaging, they showed that Ck-PEA3 and Ck-ER81 are expressed in discrete populations of motor neurons in the embryonic chick ventral spinal cord. Importantly, retrograde labelling established that individual motor pools express a speci®c complement of Ets-and LIM-proteins. These authors showed that Ets-proteins are also expressed in sensory neurons, prior to the establishment of the monosynaptic connections with their target motor neurons. Prior to the establishment of these monosynaptic connections, a majority of motor neurons express both Ck-PEA3 and Ck-ER81. When the connections form, the expression pattern changes dramatically, since 90% of the sensory aerents now express either Ck-PEA3 or Ck-ER81. However, this correlation between Ets-genes expression is not absolute, as a low number of sensory neurons expressing Etsproteins contact motor neurons that do not express the coordinate Ets-genes. This lack of correlation probably implies that additional factors must contribute to the exact match of sensory and motor neurons in a given motor unit. A second remarkable ®nding is that the coordinate expression of genes de®ning a neuronal circuit is under the control of peripheral signals originating from the target muscle.
Ck-Tel: (EMBL accession number: AF075705); this gene was cloned and found expressed in spinal motor neurons (Lin et al., 1998) . But its low level of expression precluded a detailed analysis of its expression. Tables 1 and 2 summarize Ets-gene expression in Xenopus and chicken during embryogenesis and in adult tissues. For a given gene, increasing levels of expression are indicated by symbols ranging from (+) to (+++). Quantitative comparisons can only be made within columns (levels of expression of a given gene in dierent tissues) but not within lines (expression levels of dierent genes in a unique tissue).
Specificity of the hybridization signal
The high sequence homology existing between the dierent members of the Ets-family genes and the observation of somewhat overlapping expression domains raise the question of the speci®city of the labelling patterns observed in hybridization studies. Although there is obviously no general answer to such a question, several studies were conducted with RNA probes containing or not the most conserved sequences, encoding the DNA binding domain (see MuÈ nchberg and Steinbeisser, 1999; Meyer et al., 1997; Dhordain et al., 1995) . Identical expression patterns were reported for the two types of probes, demonstrating that crosshybridization on closely related sequences was generally not a serious problem. However, experiments have to be conducted under the highest possible stringency, to avoid hybridization on transcripts of other members of the family. For instance, in our early study of Xl-Fli-1 gene expression by Northern blotting , the 6/7-kb mRNA described as a Fli-1 transcript was most likely an Xl-Erg transcript revealed because of insucient stringency. Expression transcription . . ., as detected by whole-mount in situ hybridization) is indicated by + or 7 and nd means no data available. Relative amounts of transcription for individual gene are indicated by +/7 to +++ but do not re¯ect the levels of transcription of the dierent genes in a single embryo. (*) GABP expression, as followed by EMSA (Chen et al., 1990) . Genes belonging to the Ets-family are usually highly fragmented and can give rise to dierent transcripts, resulting either from alternative splicing, or from the usage of multiple promoters. Xl-Fli-1, Cc-Fli-1, Ck-Ets-1 and Hu-Ets-2 genes are transcribed from at least two dierent promoters. (Dhulipala et al., 1998; Mager et al., 1998; Begue et al., 1997; Crepieux et al., 1993) . Usage of dierent initiation codons under the control of upstream open reading frames was shown to result in two dierent proteins for the murine Fli-1 gene (Sarrazin et al., 2000; Starck et al., 1999a) . This leaves a potential for cell-type speci®c expression of dierent isoforms of these transcription factors. For instance, the two dierent Ck-Ets-1 p54
c-ets-1 and p68
c-ets-1 transcripts were shown to be expressed in dierent cell types. The same holds true for both chicken Erg isoforms, which are expressed dierentially in chondrocytes (Iwamoto et al., 2000) . The shorter form maintains chondrocytes in an immature state, while the longer form favours dierentiation and mineralization. It is therefore more and more likely that Ets-genes play important roles in dierentiation processes. Vascularization, angiogenesis and hematopoiesis: As reported above, several members of the Ets-gene family were found expressed, during embryogenesis, in the very primitive hemangioblasts, which are the precursors of hematopoietic and vascular lineages (Baltzinger et al., 1999; Mager et al., 1998; Meyer et al., 1997 Meyer et al., , 1995 Pardanaud and Dieterien-LieÁ vre, 1993; Vandenbunder et al., 1989) . Similarly, Ets-1 is expressed in ECs, during wound healing, tumour angiogenesis and re-endothelialization after denuding injury. Its expression is turned o in quiescent ECs, which characterize mature blood vessels. On the contrary, Tel, another member of the Ets-family, is not expressed in small vessels during tumour or ovarian angiogenesis. Only large mature vessels express Tel, which could plead for some functional complementarity between dierent members of the family (Edel, 1998) . Furthermore, genes speci®cally expressed in ECs, like the Tiereceptor tyrosine kinase (Iljin et al., 1999) , von Willebrand factor (Schwachtgen et al., 1997) , vascular endothelial cadherin (Gory et al., 1998) and the endothelial growth factor receptor ®t-1 (Wakiya et al., 1996) are controlled by Ets-genes. These results suggest an important role of these genes in dierentiation of ECs and blood vessel formation. Several interference experiments recently supported this hypothesis. Overexpression of Xl-Fli-1 during Xenopus embryogenesis leads to the ectopic formation of endothelial cisternae, ®lled with erythrocytes, but not connected to the vasculature (Remy et al., 1996) . Interestingly, a similar phenotype was reported for mice embryos de®cient in VE-cadherin (Gory-FaureÂ et al., 1999) . Overexpression of Fli-1 in transgenic mouse results in death from progressive immunological disease, suggesting a role of Fli-1 in autoimmunity (Zhang et al., 1995) . The recent knockout of Fli-1 in mouse embryos (Spyropoulos et al., 2000) , led to haemorrhage, impaired hematopoiesis and death of the embryo, strengthening the concept that Fli-1 regulates key aspects of hematopoiesis. Inhibition of Ck-Ets-1 by constitutive expression of a dominant negative form increases adhesion of ECs and stimulates capillaries formation (Mattot et al., 2000) . Inhibition of Ck-Ets-1 function by an antisense oligonucleotide approach results in the impairment of blood vessel formation on the chick chorioallantoic membrane (Wernert et al., 1999) . However, it should be noted that recent knockout of Ets-1 in the mouse yielded viable mice (Barton et al., 1998) , suggesting that Ets-1 is not essential for vasculature formation. This apparent discrepancy could result from functional redundancy between members of the Ets-family, as we have seen that several dierent Ets-genes were expressed in ECs. For instance, overexpression of Xl-Erg during Xenopus embryogenesis results in the ectopic dierentiation of ECs (Baltzinger et al., 1999) .
The importance of Ets-genes in the dierentiation of lymphoid, myeloid and erythroid lineages has been abundantly illustrated (Pereira et al., 1999; Nerlov and Graf, 1998 ; for review, see Bassuk and Leyden, 1997; Ghysdael and Boureux, 1997) . Accordingly, the promoter regions of many genes expressed in blood cells contain Ets-binding sequences (EBS) and are transactivated by Ets-proteins (for review, see Bassuk and Leyden, 1997) . For instance, the human CD4- (Salmon et al., 1993) , the thrombopoietin- (Kamura et al., 1997) and the thrombopoietin receptor-promoters (Deveaux et al., 1996) were shown to be activated by Ets-proteins. Deregulation of genes belonging to the Ets-family, either upon translocations or provirus insertion frequently yields hematological diseases (for review, see Dittmer and Nordheim, 1998; Truong and Ben-David, this issue) . A very thorough analysis of Ets-genes (Erg, Ets-1, Ets-2, Fli-1, Tel, Elf-1, GABPa, PU.1 and Spi-B) contribution to lymphoid speci®cation and commitment was recently reported in the mouse by Anderson et al. (1999) . It showed a very complex, precise, and dramatic regulation of dierent Ets-family factors in the course of lymphocyte development. A similar speci®city was already reported by Lin et al. (1998) in developing neurons, making it very unlikely that Ets-genes are essentially equivalent, despite their apparent lack of speci®city for target sequences and apparent redundancy in the regulation of dierent gene promoters. Combinatorial interactions between Etsproteins and/or other transcriptional regulators could explain this apparent contradiction.
Neural crest cells and their derivatives: several genes belonging to the Ets-family are expressed in the neural crest cells at premigratory and migrating stages. Clearly, subpopulations of neural crest cells express dierent combinations of Ets-genes (Tables 1 and 2 ). Whereas Fli-1 is only expressed in cranial crest cells destined to become mesenchymal cells (Mager et al., 1998) and later cartilages of the head and neck (Sadaghiani and ThieÂ baud, 1987) , Ets-1 and 2 are transcribed in neural crest cells destined to become either mesenchymal or neural . The role of Fli-1 in cartilage formation is supported by the observation that Ck-Erg, a close relative of Fli-1, is expressed in the chick sclerotome, progenitor of the vertebra (Dhordain et al., 1995) . As already mentioned, two isoforms of Ck-Erg are dierentially expressed in chondrocytes and have dierent functions (Iwamoto et al., 2000) . Thus, dierent members of the Ets-family are expressed at dierent times as well as in speci®c lineages in neural crest cells, suggesting that in this system, these genes are not redundant, but could play complementary roles.
Development of the kidney: whereas a diuse expression of Xl-Fli-1 (Meyer et al., 1995) and CkEts-1 (Dhordain et al., 1995) are observed along the pronephric duct migration pathway, Xl-Ets-2 (Meyer et al., 1997) and XER81 (Chen et al., 1999; MuÈ nchberg and Steinbeisser, 1999) transcripts are present in the epithelial structure of the growing pronephric duct. This could mean that Xl-Ets-2 and XER81 are important for the maintenance of pronephric epithelia, whereas the expression of Fli-1 and Ets-1 in mesenchyme is required for these cells to undergo the mesenchymal to epithelial conversion. Cranial neural crest cells and pronephric duct cells have been shown to have partially overlapping guidance cues (Thibaudeau et al., 1993; Zackson and Steinberg, 1986) . The role of Fli-1 in the mesenchymal cells could be to control the expression of constituents of the extracellular matrix (see below), indispensable for pronephric duct growth or guidance. The above observations would plead for a complementarity or synergism in the functions of these genes, rather than for a complete redundancy.
Proliferation
The genes of the Ets-family exhibit marked structural and functional similarity. The founder of the family, Ets-1, is the precursor of a retroviral oncogene and deregulation of Ets-gene expression is often associated with tumorigenic processes (for review, see Dittmer and Nordheim, 1998; Sharrocks et al., 1997) . These indirect arguments tend to implicate these genes in the control of cellular proliferation. For instance, Ets-2 is expressed at high level in regenerating liver (Bhat et al., 1987) ; furthermore, Ets-2 was shown to regulate cdc2 (Wen et al., 1995) and cyclin D1 (Albanese et al., 1995) in mammals; inhibition of Ets-2 function by antisense mRNA or a dominant negative mutant yields a reduction of anchorage independent growth (Sementchenko et al., 1998). Ets-family genes belonging to six dierent subgroups (comprising the TCFs) are the targets of signalling pathways involving Neu/ErbB-2 (Galang, et al., 1996) and the downstream Ras (for review, see Wasylyk et al., 1998) . Accordingly, the Ets-2 DNA-binding domain also suppresses mitogenic signalling by CSF-1 and Ras (Langer et al., 1992) ; Ras transformed cells revert upon expression of dominant negative deletion mutants of Ets-1, Ets-2 and PU.1 (Wasylyk et al., 1994) . Ras mediated regulation by Etsproteins involves interactions with other protein partners, AP-1 on Ras responsive elements (for review see Wasylyk and Nordheim, 1997) , SRF on serum response elements (Treisman, 1994) . Phosphorylation of speci®c residues of Ets-proteins by MAP-kinases plays an important role in Ras-mediated activation of the transcriptional activity of Ets-proteins.
Other genes of the family are also involved in controlling cell proliferation. Fli-1 was shown to inhibit dierentiation and induce proliferation of primary erythroblasts (Pereira et al., 1999; Starck et al., 1999b) , in agreement with the phenotypes linked to Xl-Fli-1 overexpression during Xenopus embryogenesis (Remy et al., 1996) . This eect of a constitutive expression of Fli-1 in erythroblasts was ascribed to a down-regulation of the retinoblastoma protein (Tamir et al., 1999) . On the contrary, early reports suggested that Ets-1 could rather be associated to a quiescent state of the cell. For instance, Ets-1 was downregulated during T-cell activation, whereas Ets-2 was strongly induced. Late after stimulation, Ets-1 mRNA was reinduced and maintained at a high level, while Ets-2 gene expression decreased to undetectable levels (Bhat et al., 1990) . Ets-1 was clearly associated to the maintenance of a quiescent state of T-cells. Ets-1 de®cient T-cells were unable to undergo activation in response to stimulation by anti-CD3 antibodies or conA (Bories et al., 1995; Muthusamy et al., 1995) . An increased sensitivity to apoptosis of the Ets-1 de®cient T-cells was also observed.
However, con¯icting results were reported as to the role of Ets-genes in triggering programmed cell death. Recent results from our laboratory (GoltzeneÂ et al., 2000) showed that forced expression of Xl-Fli-1 in animal cap cells results in modi®cation of cell ± cell and cell ± matrix adhesion, accompanied by an increased engagement in apoptosis. PU.1 was reported to enhance apoptosis in murine erythroleukemic cell lines, in response to DMSO-induced dierentiation (Oikawa et al., 1999; Yamada et al., 1997) . Isoforms of the Ets-1 protein increase apoptosis in human colon cancer cells (Huang et al., 1997; Li et al., 1999) . Constitutive expression of two splice variants of the Elk-1 gene induces apoptosis in rat ®broblasts and breast cancer cells (Shao et al., 1998) . On the contrary, Fli-1 inhibits apoptotic cell death program normally activated in erythroblasts following Epo deprivation (Pereira et al., 1999) . Similarly, Ets-2 rescues cell death in CSF-1 starved macrophages (Sevilla et al., 1999) . A knockout of the murine Tel gene leads to the death of the embryo, because of intraembryonic apoptosis of mesenchymal and neural cells (Wang et al., 1997) . Finally, normal and aberrant Fli-1 and Erg proteins inhibit apoptosis of NIH3T3 cells deprived of serum or treated with a calcium ionophore (Yi et al., 1997) . Clearly, such a divergence in the results could arise from dierences in the cellular contexts of all these experiments.
Epithelium to mesenchyme and mesenchyme to epithelium transitions
Epithelium to mesenchyme transition (EMT) is a morphogenetic event which takes place throughout the entire embryo and leads to the formation of a number of basic tissues (for review, see Hay, 1995) . The heart, the somites, the kidneys and the neural crest are sites of EMT. Mesenchyme to epithelium transition (MET) is a rarer event in development. It takes place in somites, kidneys and testis. Sites of mesenchymal cells condensation (precartilaginous condensations, dermal condensations in feather formation) probably proceed from the same mechanism. Excretory tubules, form by a direct MET induced by the tips of the developing collecting duct system invading a specialized mesenchyme (Davies, 1996) . A mesenchymal cytokine, hepatocyte growth factor (HGF), also known as scatter factor (SF), and its receptor c-MET appear to play an important role in EMT. Indeed, SF was shown to induce cell dissociation, proliferation and branching morphogenesis (Montesano et al., 1991; Stocker et al., 1987) . Experimental evidence accumulates, suggesting an important role of Ets-family genes in the control of this process. Indeed, the embryonic territories expressing dierent Ets-genes are also the sites of active EMT (Macias et al., 1998; Mager et al., 1998; Fafeur et al., 1997; Majka and McGuire, 1997; Meyer et al., 1995 Meyer et al., , 1997 . At the molecular level, several studies have brought evidence for a crossregulation of Ets-genes expression and HGF/c-MET function (Gambarotta et al., 1996; Hanzawa et al., 2000) . This cross-regulation may even be indirect, since HGF/c-MET signalling was shown to activate Ras, by stimulating guanine nucleotide exchange (Graziani et al., 1993) . Interestingly, a new subfamily of Ets-genes (ESE-1 / ESX / JEN / ERT / ELF3; ESE-2 / ELF5; ESE-3 / EHF) has recently been shown to be speci®cally expressed in epithelia Oettgen et al., 1997 Oettgen et al., , 1999 Oettgen et al., , 2000 . Both ESE-1 and ESE-3 were shown to bind the promoter region of the HGF receptor cMET, but only ESE-3 is able to transactivate it .
Mesenchyme to epithelium transition is important in kidney tubules formation. It is worth reminding that in Xenopus, the Xl-Fli-1 gene is expressed in a diuse pattern in the mesenchymal cells along the migration pathway of the pronephric duct, whereas Xl-Ets-2 is strongly expressed in the proper epithelium of pronephric duct and tubules (Maroulakou et al., 1994; Meyer et al., 1995 Meyer et al., , 1997 . These genes are therefore likely to serve complementary functions in the conversion of mesenchyme to epithelium during nephrogenesis. We also showed that discrete islets of cells in the peri-anal region of the Xenopus embryo strongly express Xl-Fli-1. It is tempting to assume that these Xl-Fli-1 positive cells are to be recruited in the growing pronephric duct, in agreement with the earlier work of Cornish and Etkin, (1993) showing that the formation of the pronephric duct in Xenopus involves recruitment of posterior cells by migrating pronephric duct cells. The Erg gene, closely related to Fli-1, could serve a parallel function in the condensation of mesenchyme cells in cartilage precursors.
Cell migration
A feature shared by many Ets-genes is their expression in migratory cells: neural crest cells, ECs, pronephric duct cells, precursors of germinal cells for instance. Many recent reports implicate Ets-genes in the migration potential of normal and transformed cells. The expression of Ets-1 in ECs is upregulated by angiogenic factors, and in turn Ets-1 converts ECs to angiogenic invasive phenotype (Oda et al., 1999) . Parallel, interference with Ets-1 function upon expression of a dominant negative mutant increases endothelial cell adhesion (Mattot et al., 2000 ; DelannoyCourdent et al., 1998); antisense oligonucleotides to Ets-1 mRNA inhibit VEGF-induced migration of human umbilical vein ECs (Chen et al., 1997) . Ets-1 was also ascribed a critical role in tumour metastasis (Kitange et al., 1999; Pande et al., 1999) . A similar observation was reported for PEA3 (Habelhah et al., 1999) , whereas Tel expression seems to have the opposite eect in breast carcinoma (Edel, 1999) . Opposite roles of dierent members of the Ets-family could help to maintain homeostasis in cell migration.
EMT and cell migration have in common to involve a deep modi®cation of cellular adhesion (Ekblom, 1989; Huttenlocher et al., 1995) . It can be expected that migratory cells will orchestrate a decrease of cell ± cell interactions (essentially under the control of cadherintype molecules). A localized increase in cell ± matrix recognition (at the leading edge at least), will likely be modulated by control of the population of integrins present at the cell surface and/or constituents of the extracellular matrix (ECM; see paper by M Trojanowska, in this issue). Of utmost importance is the control of ectocellular proteases, capable of degrading locally the ECM, thereby facilitating cell dispersion and migration. This last point will of course be critical for metastasis.
We have recently shown that Xl-Fli-1 heterotopic expression in the animal cap cells of Xenopus embryos leads to marked modi®cations of cellular adhesion (GoltzeneÂ et al., 2000) ; adhesion to constituents of the ECM, like ®bronectin and laminin is decreased, whereas no eect is observed on collagen or vitronectin. A lack of adhesion to transferred ECM of the blastocoel roof is also observed. Parallel to these modi®cations, animal cap cells expressing Xl-Fli-1 also acquire new cell ± cell recognition speci®city, most likely re¯ecting perturbations of the population of cadherins expressed at the cell surface. E-cadherin is closely associated with epithelial tissues and is downregulated during epithelial-mesenchymal transitions and in many epithelial cancers. E-cadherin appears to play an important role in the development and progression of cancer (for review, see Vallorosi et al., 2000; Nollet et al., 1999) . Strikingly, the promoter of the E-cadherin gene contains a negative Ets-regulatory element and the negative regulation by endogenous Ets-protein(s) can be circumvented by exogenous Ets-1 and ERM (Rodrigo et al., 1999) , suggesting that Ecadherin level might be regulated by competition of dierent Ets-proteins for its promoter. VE-cadherin, strictly speci®c to endothelial cells and critical for vascularization (see above), contains in its promoter two Ets binding sites (EBS), essential for promoter activity. ICAM-1, an intercellular immunoglobulinetype adhesion molecule is also positively regulated by Ets-2 and ERM . The expression of genes encoding integrin subunits is also controlled by Ets-proteins: a 4 (Rosen et al., 1994) , aV (Tajima et al., 2000; Donahue et al., 1994) , aX (Noti et al., 1996 ), b2 (Bo È ttinger et al., 1994 Rosmarin et al., 1995 Rosmarin et al., , 1998 , b3 (Oda et al., 1999) , b4 (Takaoka et al., 1998) .
Few studies report a control of ECM constituents by Ets-genes. A recent publication reports the reciprocal expression of Ets-1 and Ets-2 during osteoblasts proliferation and dierentiation, accompanied by a transcriptional control of the osteopontin gene by Ets-2 (Vary et al., 2000) . The expression of tenascin, a constituent of ECM, expressed at sites of epithelialmesenchymal transformation, was shown to be controlled by several members of the Ets-family: Ets-1, Ets-2, GABPa+b1 and Fli-1 (the most potent activator). GABPa+b1 and Fli-1 were shown to cooperate synergistically with Sp1 in tenascin upregulation (Shirasaki et al., 1999) . A recent work brings evidence for a control of tenascin expression by an isoform of Ck-Erg (Iwamoto et al., 2000) . Interestingly, chondrocytes expressing the short isoform of Ck-Erg and expressing tenascin are round cells. This keeps in line with a decreased cell ± matrix adhesion and the putative anti-adhesive role ascribed to tenascin (Mackie, 1997) . Surprisingly, unpublished results of our laboratory show a disappearance of tenascin at the level of the ectodermal blisters resulting from Xl-Fli-1 overexpression during Xenopus embryogenesis (Remy et al., 1996) . This eect could be due to a localized degradation of tenascin by secreted proteases. Indeed, several Ets-genes are able to transactivate metalloproteinase genes (for review, see Westermarck et al., 1997; Buttice et al., 1996; Buttice and Kurkinen, 1993; Wasylyk et al., 1991) , as well as tissue inhibitors of metalloproteinases (Logan et al., 1996; Edwards et al., 1992) . ECM localized degradation is indeed a critical factor for cellular migrations, either physiological (Oda et al., 1999; SteÂ helin, 1998; Luton et al., 1997; Iwasaka et al., 1996) or pathological (Hanzawa et al., 2000; Habelhah et al., 1999; Westermarck et al., 1997; Higashino et al., 1995) . A major contribution to the understanding of how metalloproteinases may contribute to cell invasive character has been published quite recently (Hotary et al., 2000) . The authors show that membrane anchored proteinases (MT-MMPs) play a major role in matrix invasion and morphogenesis, whereas the secreted forms are devoid of morphogenetic activity. Furthermore, the level of expression of MT-MMPs at the cell surface is likely to control the engagement in a degradative or morphogenetic program. These observations open new important questions (Quaranta, 2000) .
Speci®city of function within the Ets-family of transcription factors
Ets-family transcription factors have been shown to recognize speci®c sequences in the regulatory regions of many genes. Most Ets-genes are able to recognize a GGAA/T core motif (for review, see Wasylyk et al., 1993) , although the eciency of binding may be modulated by bases adjacent to this core motif. Clearly however, this sequence recognition cannot account for a speci®c gene regulation during complex developmental processes. Other mechanisms have to be at work, among which: (i) unique cell type speci®c expression; (ii)`combinatorial' regulation, involving protein ± protein interactions or ternary complex formation.
Cell type speci®c expression: Signi®cant progress in the elucidation of the role of Ets-genes in cell type speci®cation came from studies of the development of the nervous system. Early experiments had revealed that several Ets-genes are expressed in dierent cell types in the nervous system. For instance, Ets-1, Ets-2 in humans (Amouyel et al., 1988) , Pointed P1 and P2 in Drosophila (Klaes, et al., 1994; KlaÈ mbt, 1993) , were shown to be speci®cally expressed in glial cells. Interference experiments with the Pointed function showed that expression of Pnt-1 in glial cells is able to force a dierentiation step in neighbouring neurons. Implication of Ets-genes in neural cell identity also came out from a study of the PEA3 subgroup in the mouse embryo, ERM, ER81 and PEA3 exhibit a dierential expression in the central nervous system, cranial-and dorsal roots ganglia (Chotteau-LelieÁ vre et al., 1997) . One of the central problems of nervous system development lies in the speci®cation and formation of synaptic connections. Recent work shed some light on the molecular aspects of these processes. A sophisticated study in the chick embryo showed that functionally related motor neuron pools and muscle sensory aerent subtypes, forming a`re¯ex unit' were characterized by coordinate Ets-gene expression (Lin et al., 1998) . Motor neurons of the lateral motor columns (LMC) can be distinguished from other motor neurons by their pattern of expression of LIM-homeodomain genes. In addition to this speci®cation, subgroups of motor and sensory neurons in the lumbo-sacral region exhibit speci®c and coordinate expression of either ER81 or PEA3, depending upon the muscle they contact. However, the fact that this correlation is not absolutely exact, leaves place for other genes in the ®ne matching of sensory and motor neurons that de®ne an individual motor unit (Ghosh and Kolodkin, 1998) . Lin et al. (1998) also showed that the coordinate expression of Ets-genes in a given motor unit was under the control of a peripheral signal, most likely emanating from the target muscle. The authors raise the hypothesis that matching of Ets-proteins expression by sensory and motor neurons could rely on cell surface properties, involving homophilic interactions. Cadherins, homophilic adhesion molecules, have already been shown to participate in the establishment of regional-speci®c neuronal connections (Suzuki et al., 1997) . Furthermore, cadherins have been implicated in de®ning subgroups of neural crest cells Nakagawa and Takeichi, 1995 ). Lin's study was completed by a work conducted in mouse (Arber et al., 2000) leading to similar conclusions. In mouse as in chick, the expression of ER81 and PEA3 de®nes distinct motor neuron pools, which appear to contact the functional homologues of the chick muscles innervated by ER81 + and PEA3 + LMC neurons. These experiments also showed that ER81 controls the formation of a ventral aerent termination zone, rather than the process of synaptogenesis itself.
Another gene of the Ets-family (Pet-1) was shown to be speci®cally expressed in central serotonin neurons (Hendricks et al., 1999) and to bind PEA3 binding sites. Accordingly, Pet-1 binding sites are found in or near the promoter regions of human and murine 5HT1a receptor, serotonin transporter, tryptophan hydroxylase and aromatic L-amino-acid decarboxylase genes, all of which are characteristic of the serotonergic neuron phenotype.
Quite recently, ERM, another gene of the PEA3 subgroup, was reported to distinguish rat satellite glia from Schwann cells, in response to extracellular signalling by NRG1, through Ras/MAP-kinase pathway (Hagedorn et al., 2000) . Earlier results had already emphasized the importance of the Ets-domain GABP transcription factors for the NRG1 or MAP-kinase dependent regulation of acetylcholine receptor (AchR) d and e subunits gene expression at the neuromuscular junction (Schaeer et al., 1998) . GABPa subunit was shown to be regulated in the subsynaptic nuclei by heregulin signalling. The latter also accounts for a MAP-kinase dependent phosphorylation of GABP subunits, further stimulating AchR expression.
Other genes, expressed in the nervous system were also shown to be controlled by Ets-genes. The promoter of human synapsin II (a neuron speci®c phosphoprotein binding synaptic vesicles in the presynaptic nerve terminal) harbours EBS recognized by PEA3 (Petersohn et al., 1995) . Similarly, the human neuro®lament light chain is under control of promoter/ enhancer elements, harbouring EBS (Charron et al., 1995) . The peripherin gene, encoding a neuron-speci®c intermediate ®lament protein is controlled by Etsproteins bound to an EBS, separated from an`orphan' new inverted repeat by 38 bp (Chang and Thompson, 1996) . Interactions appear to take place between the Ets-transcription factor and the unidenti®ed protein binding the inverted repeat. Presenilin genes encode integral membrane proteins, whose mutations lead to the most aggressive form of familial Alzheimer's disease. An EBS, close to ELK binding motif, is encountered in the proximal promoter of Presenilin-1, which is bound by Ets-proteins recognized by an antibody with a broad cross-reactivity with Ets-1 and Ets-2 proteins (Pastorcic and Das, 1999) . The authors suggest that interactions with cofactors could be responsible for this modi®cation of the speci®city of recognition. They also report a competition with p53 upon binding to an acceptor-site close to the EBS. Finally, an enhancer (b43'), harbouring three dierent EBS, controls the nicotinic acetylcholine receptor subunit gene cluster. This enhancer is composed of two direct repeats of 37-bp separated by a 6-bp spacer (Mcdonough and Deneris, 1997) . This enhancer is dependent upon the binding of Ets proteins for its activity (Mcdonough et al., 2000) . The EBS present in the spacer is probably bound by Ets-1/Ets-2. Indeed, antibodies having a broad speci®city against Ets-1 and Ets-2 DNA-binding domain as well as a dominant negative form of Ets-2 decrease enhancer activity to a level comparable to the one obtained for a promoter harbouring a mutation in the spacer Ets-site. The authors postulate that Pet-1 is a good candidate for the endogenous PEA3-type Ets-factor binding the enhancer repeat in adrenal and chroman cells, although anti-Pet-1 antibodies failed to supershift complexes made on the repeat. They hypothesize that Pet-1 or related Ets-factors regulate genes required for the expression of two dierent neurotransmitter systems in dierent kinds of neurons (Mcdonough et al., 2000) .
Combinatorial regulation: The broad speci®city of target sequence recognition by isolated Ets-proteins implicates that a precise regulation of gene expression can only be achieved through interactions with accessory proteins, able to modulate the anity and/ or speci®city of EBS recognition, as well as the stimulation or inhibition of transcription (see paper by R Li and DK Watson, in this issue). Although Etsproteins essentially contact DNA under a monomeric form, GABP is composed of two dierent subunits a and b, and is usually present under a tetrameric form. A few more interactions between Ets-transcription factors have been revealed. Erg proteins are capable of forming homo-and heterodimers with other Etsproteins (CarreÁ re et al., 1998) . Among the latter, Fli-1, Ets-2, ER81 and PU.1 were shown to physically interact with Erg. Tel, an inhibitory Ets-protein, able to dimerize, also forms a complex with Fli-1, via the HLH pointed-domain and inhibits its transcriptional activity (Kwiatkowski et al., 1998) .
Complex formation may also involve many types of accessory proteins. The TCF subfamily of Ets-genes is known to form complexes with the serum response factor, at the level of serum response elements in promoters (for review, see Treisman, 1994 ; also see paper by Yordy and Muise-Helmericks in this issue). EWS-Fli-1 and Fli-1 were recently added to the list of Ets-proteins interacting with SRF (Dalgleish and Sharrocks, 2000; Watson et al., 1997; Magnaghi-Jaulin et al., 1996) . Erg was shown to interact with an AP1 complex (Buttice et al., 1996) , as several other Etsproteins (Bassuk and Leiden, 1995) . More recently, the list of partners of Ets-proteins kept growing. Complexes between C/EBP and Ets-1 or Fli-1 are involved in the regulation of eosinophil speci®c expression (McNagny et al., 1998) . Although the proteins interact by their DNA-binding domains, they bind their combined binding site cooperatively. PU.1 was already reported to play an important role in erythroid dierentiation. A functional antagonism was recently detected with GATA-1, a zinc ®nger transcription factor required for erythropoiesis (Rekhtman et al., 1999) . Both molecules interact in the absence of DNA. The transactivation and DNA-binding domains of PU.1 are required for this interaction (Rekhtman et al., 1999) . Accordingly, ectopic expression of PU.1 in Xenopus embryos is sucient to block erythropoiesis. The same PU.1 factor was also shown to interact with goosecoid (Konishi et al., 1999) . This interaction competes with the binding to PU.1 of the retinoblastoma protein, a tumour suppressor gene presumably involved in erythropoiesis. MafB, an AP1-like protein binds to Ets-1 DNA-binding domain and inhibits its transactivation capacity, particularly towards the transferrin receptor gene, known to be essential for erythroid dierentiation (Sieweke et al., 1997 ). An intricate set of interactions between Ets-proteins and accessory proteins appear to be at work in the dierentiation of blood cell lineages, sometimes with some contradictory aspects. Ets-1 and AML-1 cooperate in the transactivation of the T-cell receptor b chain enhancer. Strikingly, both molecules interact via their autoinhibitory domains, therefore enhancing their binding activity and transactivating function (Kim et al., 1999) . Fli-1, Ets-1 and GABP are able to bind Paxproteins, via a b-hairpin of the paired-domain, therefore increasing their speci®city (Wheat et al., 1999) . Net, a negative Ras-switchable TCF is able to bind to CtBP (E1A terminal binding protein), mediating repression through a deacetylase activity (Criqui-Filipe et al., 1999) . STAT5, a transcription factor activated by many cytokines, physically and functionally interacts with Ets-1 and Ets-2 (Rameil et al., 2000) ; this interaction appears to require the IL-2-induced dimerization of STAT5 and could contribute to the proliferative response to IL-2. In addition to the pointed domain involved in dimerization or interaction with Fli-1, the Tel protein contains a central region able to recruit a repression complex (Chakrabarti and Nucifora, 1999) , including SMRT, a corepressor for nuclear receptors and mSin3A, often associated to histone deacetylase activities (Kao et al., 2000) . Tel joins a growing family of transcriptional repressors interacting with SMRT, mSin3A and N-CoR, and which are rearranged by chromosomal translocations. This could therefore constitute a common mechanism of alteration of gene transcription, leading to cell transformation. Finally, Daxx, a general non-DNA binding repressor, ubiquitously expressed, was recently shown to interact with the N-terminal region of Ets-1, comprising the pointed domain and the adjacent site of phosphorylation by MAP-kinases .
Conclusion, perspectives
There is now a growing set of experimental results implicating Ets-transcription factors in the control of embryonic development. These genes appear to play important role in the proliferation, dierentiation and survival of many cell lineages. If they were initially considered as exerting largely redundant functions, their coordinate expression was recently shown to participate in de®ning a`cellular identity', thus allowing cell recognition processes. These cellular interactions are probably mediated via molecules of the cellular surface, able to relay environmental information to the nucleus and to trigger an adaptative response (dierentiation, proliferation, survival or death). Among these cell surface molecules, homophilic adhesion molecules like cadherins and cell ± matrix adhesion molecules are likely to play an important role. Their participation in making a choice of life or death has already been abundantly illustrated. Recent insights in the family of cadherins have been very mind stimulating (Yagi and Takeichi, 2000) . Individual neurons might express dierent combinations of the cadherin-superfamily proteins at synaptic sites. Their combinatory expression could confer an enormous variation of adhesive properties to neurons. These observations give us the feeling to have a deeper insight into the molecular mechanisms generating an enormous number of diversi®ed neurons and their speci®c interactions. This could be an open window on brain function, including innate and acquired behaviour.
Further studies should increase our knowledge of the relation between coordinate expression of the dierent Ets-genes (including the dierent isoforms they generate) and acquisition of a cellular identity. On a technical point of view, new sensitive¯uorescence techniques allowing the precise localization of mRNAs or proteins, coupled to the resolving power of confocal microscopy should allow a more accurate description of expression at the cellular level. The development of a reliable in situ PCR methodology, respecting tissue structure, should facilitate the study of the dierential expression of isoforms, upon ampli®cation of short sequences, which dierentiate transcripts of a given gene.
